Skip to content
lifestyle.social-matic.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Biosplice Therapeutics, Inc.
European Medicines Agency Validates Biosplice’s Application for Lorecivivint (LOR) in Knee Osteoarthritis and Begins Review
October 2, 2026
Lorecivivint for Knee OA: UK MHRA Accepts Biosplice Application
September 8, 2026